Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Use of IVUS in Complex PCI: Results according to Operator Experience

The use of ultravascular ultrasound (IVUS) to guide coronary angioplasty procedures (PCI) has been shown to reduce the risk of major adverse events in numerous randomized controlled studies, registries and meta-analysis. 

¿Es frecuente el uso de IVUS para guiar la ATC?

The current guidelines recommend the use of IVUS in left main disease and complex lesions. The proportion of complex PCI procedures has increased over time, as well as operator experience. 

Several studies have shown high volume centers, or those with experienced operators, are associated with a significant reduced risk of major adverse cardiovascular events vs. low volume centers or those with less experienced operators. 

The aim of this retrospective, observational study was to to evaluate the influence of operator experience on lesion complexity, long-term clinical outcomes, and the interactions of IVUS guidance in patients undergoing complex PCI. 

Read also: Retrograde Approach to Chronic Total Occlusions: Techniques and Outcomes According to the PROGRESS-CTO Registry.

Primary end point was a combination of cardiovascular death or target vessel MI (TVMI) at 10 years. Secondary end point included cardiac death rate at 10 years, acute MI, TVMI, definite or probable stent thrombosis and ischemia driven target lesion revascularization (TLR).

From the total of patients with complex coronary artery disease, 63.4% received PCI from experienced operators, while 36.6% received PCI from less experienced operators. 

Experience operators used IVUS more frequently in complex lesions and had higher annual volume of PCI vs. less experienced operators. Also, more experience operators presented higher SYNTAX score, higher number and longer lesions, with more left main compromise.  Patients receiving IVUS guided PCI were younger, and had fewer cardiovascular risk factors, and prior MI and cardiovascular events. 

Read also: Dissection and Re-Entry Technique in Chronic Total Occlusions: Data from the PROGRESS-CTO Registry.

As regards outcomes, experienced operators saw lower risk of cardiac death or TVMI vs. less experienced operators (HR: 0.779; CI 95%: 0.663-0.915; P = 0.002). The use of IVUS was associated with a significant lower risk of cardiac death and TVMI vs angiography guided PCI, both for less experienced (23.5% vs 11.4%; HR: 0.477; CI 95%: 0.337-0.673; P < 0.001) and more experienced operators (18.0% vs 13.5%; HR: 0.747; CI 95%: 0.559-0.998; P = 0.048). There was a significant interaction for the risk of cardiac death or TVMI between the use of IVUS and operator experience (P=0.037).

Conclusion

Between patients with complex CAD, the use of IVUS guided PCI was associated with better long term outcomes vs. angiography guided PCI, regardless operator experience. Also, the beneficial effects of IVUS were more prominent when complex PCI procedures were carried out by less experienced operators. 

Dr. Andrés Rodríguez

Dr. Andrés Rodríguez.
Member of the Editorial Board of SOLACI.org.

Original Title: Prognostic Impact of Operator Experience and IVUS Guidance on Long-Term Clinical Outcomes After Complex PCI.

Reference: Ki Hong Choi, MD, PHD et al J Am Coll Cardiol Intv 2023;16:1746–1758.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...